Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical PracticeHideki Iwamoto, Tomotake Shirono, Takashi Niizeki et al.|Cancers|2021Cited by 59
Durable complete response is achieved by balloon‐occluded transcatheter arterial chemoembolization for hepatocellular carcinomaTomotake Shirono, Takuji Torimura, Hideki Iwamoto et al.|Hepatology Communications|2022Cited by 14